Data / Form D filings / Brainsway Ltd.
Brainsway Ltd.: Form D filing
Brainsway Ltd., a biotechnology company in Jerusalem, Israel, filed a Form D with the SEC in 2024. The latest, on October 15, 2024, reports $20 million sold of a $20 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 16 HARTUM STREET, RAD TOWER, 14TH FLOOR, HAR HAHOTZVIM, Jerusalem, Israel, 97775
- Phone
- +972-2-582-4030
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Israel
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1505065
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 15, 2024 | New notice | $20,000,009 | $20,000,009 | 1 | Sep 29, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Hadar Levy | Executive Officer | |
| Yossi Ben Shalom | Director | |
| Avner Hagai | Director | |
| David Zacut | Director | |
| Ido Marom | Executive Officer | |
| Abraham Zangen | Director | |
| Eti Mitrany | Director | |
| Karen Sarid | Director | |
| Ami Boehm | Director | |
| Avner Lushi | Director |
Every Form D from the week of Oct 14, 2024 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Brainsway Ltd. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.